Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CRVO US Equity

CervoMed Inc.Health Care · Pharmaceutical Preparations · CIK 1053691 · FY ends Dec 31
$2.62
+0.06 (+2.34%)
USD · as of 2026-08-21 · marketstack
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by CVI Investments, Inc.sec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Woodline Partners LPsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by ARMISTICE CAPITAL, LLCsec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-048-K 8.01Other eventssec.gov ↗
2026-08-048-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-148-K 8.01Other eventssec.gov ↗
2026-07-148-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-098-K 8.01Other eventssec.gov ↗
2026-07-098-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by MORGAN STANLEYsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-08

Every row is a filed document, checked against its EDGAR index.